FIELD: medicine.
SUBSTANCE: method involves introducing Levamisol at a peroral dose of 50 mg twice a day during 3 days into traditional therapy after having studied patient immunity state. Rusam is concurrently intramuscularly introduced at a dose of 200 mg once a day with 4-5 days long pause. The course is 3-4 injections long.
EFFECT: selective treatment of immune system chains.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING BRONCHIAL ASTHMA CASES | 2005 |
|
RU2288741C2 |
METHOD FOR TREATING BRONCHIAL ASTHMA | 2005 |
|
RU2309755C2 |
BRONCHIAL ASTHMA TREATMENT MODE | 2008 |
|
RU2360698C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
METHOD OF TREATING HYPOTHYROIDISM | 2009 |
|
RU2407533C1 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA, EITHER INTERMITTENT, OR MIXED OF MILD SEVERITY LEVEL | 2006 |
|
RU2345774C2 |
IMMUNOMODULATING AGENT | 1995 |
|
RU2077882C1 |
METHOD OF ELIMINATION OF PSEUDOALLERGIC RESPONSE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY ILLNESSES | 1996 |
|
RU2140269C1 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
METHOD OF TREATING ATOPIC DERMATITIS IN CHILDREN WITH SECONDARY IMMUNODEFICIENCY SYNDROME | 2014 |
|
RU2542421C1 |
Authors
Dates
2006-12-10—Published
2005-01-11—Filed